Interestingly, during spinal cord neurodegenerative disease, in the case of the transgenic SOD1G86R model of ALS, Dupuis et al. (2002) first demonstrated that the level of Nogo-A increased at early stages of the disease [147]. The gene discussed is RTN4; the disease is neurodegenerative disease.